TON - July 2017, Vol 10, No 4

Here is what you can expect to read in the July issue of The Oncology Nurse-APN/PA.
The Oncology Nurse-APN/PA (TON) spoke with Gayle Jameson, MSN, ACNP-BC, AOCN, Director, Supportive Care Division, Virginia G. Piper Cancer Center, Scottsdale, AZ, about her role in conducting cancer research at HonorHealth Research Institute.
Sensitivity to cultural context is one of the keys to successful patient education and communication. An innovative program has met with success in encouraging women of Asian-Indio descent to participate in cancer screenings.
Nurse and patient navigators from all over the country attended the Academy of Oncology Nurse & Patient Navigators (AONN+) 2017 West Coast Regional Meeting in April. The meeting provided a forum for open dialogue around navigation and survivorship care services for patients with cancer, fostered lively discussions regarding the complexities of cancer care in the rapidly growing field of navigation, and led to new ideas for the improved delivery of navigation and survivorship care services.
CDK4/CDK6 inhibitors are a promising addition to the armamentarium for the treatment of patients with breast cancer. At the 42nd annual meeting of the Oncology Nursing Society, 2 experts discussed the role of these new drugs, and how to factor them into treatment decisions.
Obesity is about to overtake tobacco as a modifiable risk factor for cancer. Approximately 30% of cancers could be prevented by maintaining a normal weight and healthy lifestyle, according to 2 experts who spoke at the 42nd annual meeting of the Oncology Nursing Society.
When an oncology nurse becomes a patient with cancer, she has to rethink her identity, and will experience a torrent of emotional changes.
Chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the treatment of some hematologic malignancies. This treatment is still investigational, and none of the CAR T-cell products being studied have received FDA approval yet, but approval is expected soon.
A survivorship visit and care plan are mandated for breast cancer survivors by the National Accreditation Program for Breast Centers. These initiatives have improved the quality of follow-up care for cancer survivors and patient satisfaction, but survivorship programs are a work in progress, and some challenges remain as they evolve.
Guided by advances in genomic technology, healthcare has entered the era of precision medicine. With genetic testing now standard of care in oncology practice, cancer is at the forefront of this initiative, but providers still face many concerns.
Page 1 of 2
Results 1 - 10 of 16